Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast.

Martins IM, Cortés JC, Muñoz J, Moreno MB, Ramos M, Clemente-Ramos JA, Durán A, Ribas JC.

J Biol Chem. 2011 Feb 4;286(5):3484-96. doi: 10.1074/jbc.M110.174300. Epub 2010 Nov 29.

PMID:
21115488
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.

Castanheira M, Woosley LN, Diekema DJ, Messer SA, Jones RN, Pfaller MA.

Antimicrob Agents Chemother. 2010 Jun;54(6):2655-9. doi: 10.1128/AAC.01711-09. Epub 2010 Apr 5.

PMID:
20368396
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Epidemiology of invasive mycoses in North America.

Pfaller MA, Diekema DJ.

Crit Rev Microbiol. 2010;36(1):1-53. doi: 10.3109/10408410903241444. Review.

PMID:
20088682
[PubMed - indexed for MEDLINE]
4.

Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.

Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS.

Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.

PMID:
19546367
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.

Baltz RH.

Curr Opin Chem Biol. 2009 Apr;13(2):144-51. doi: 10.1016/j.cbpa.2009.02.031. Epub 2009 Mar 19. Review.

PMID:
19303806
[PubMed - indexed for MEDLINE]
6.

Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.

Katiyar SK, Edlind TD.

Antimicrob Agents Chemother. 2009 May;53(5):1772-8. doi: 10.1128/AAC.00020-09. Epub 2009 Mar 2.

PMID:
19258277
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.

Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Monzon A, Buitrago MJ, Rodriguez-Tudela JL.

Antimicrob Agents Chemother. 2009 May;53(5):2192-5. doi: 10.1128/AAC.01543-08. Epub 2009 Feb 17.

PMID:
19223630
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America.

Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.

PMID:
19191635
[PubMed - indexed for MEDLINE]
Free Article
9.

Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.

Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D.

PLoS Pathog. 2009 Jan;5(1):e1000268. doi: 10.1371/journal.ppat.1000268. Epub 2009 Jan 16.

PMID:
19148266
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.

Cornely OA.

Infection. 2008 Aug;36(4):296-313. doi: 10.1007/s15010-008-7357-z. Epub 2008 Jul 19. Review. Erratum in: Infection. 2008 Dec;36(6):605-6.

PMID:
18642109
[PubMed - indexed for MEDLINE]
11.

A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.

Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS.

Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12. doi: 10.1128/AAC.00262-08. Epub 2008 Apr 28.

PMID:
18443110
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Changing epidemiology of systemic fungal infections.

Richardson M, Lass-Flörl C.

Clin Microbiol Infect. 2008 May;14 Suppl 4:5-24. doi: 10.1111/j.1469-0691.2008.01978.x. Review.

PMID:
18430126
[PubMed - indexed for MEDLINE]
13.

Update on echinocandin antifungals.

Kauffman CA, Carver PL.

Semin Respir Crit Care Med. 2008 Apr;29(2):211-9. doi: 10.1055/s-2008-1063859. Review.

PMID:
18366002
[PubMed - indexed for MEDLINE]
14.

Infections caused by Scedosporium spp.

Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ.

Clin Microbiol Rev. 2008 Jan;21(1):157-97. doi: 10.1128/CMR.00039-07. Review.

PMID:
18202441
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Fusarium infections in immunocompromised patients.

Nucci M, Anaissie E.

Clin Microbiol Rev. 2007 Oct;20(4):695-704. Review.

PMID:
17934079
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Changing epidemiology of rare mould infections: implications for therapy.

Malani AN, Kauffman CA.

Drugs. 2007;67(13):1803-12. Review.

PMID:
17722951
[PubMed - indexed for MEDLINE]
17.

Resistance to echinocandin-class antifungal drugs.

Perlin DS.

Drug Resist Updat. 2007 Jun;10(3):121-30. Epub 2007 Jun 13. Review.

PMID:
17569573
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Fungal infections.

Kauffman CA.

Proc Am Thorac Soc. 2006;3(1):35-40. Review.

PMID:
16493149
[PubMed - indexed for MEDLINE]
19.

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Pfaller MA, Diekema DJ.

J Clin Microbiol. 2004 Oct;42(10):4419-31. Review. No abstract available.

PMID:
15472288
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk